|
| Exchange Disseminated Time 29/07/2016 14:12:04 | Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors will be held on August 12, 2016 to consider and approve the Company's Unaudited Financial Statements for the First Quarter ended June 30, 2016 (Q1).
Further, as per the "Code of Conduct for Prevention of Insider Trading" of the Company, the trading window closed for Directors and other designated employees of the Company on June 25, 2016 and will remain closed upto August 16, 2016 (both days inclusive) for the purpose of approval of Unaudited Financial Statements for the First Quarter ended June 30, 2016. |
|
|